Internal Medicine • Research • Visualized VISUALIZED: A Phase 2a/b Trial of Triheptanoin for Ataxia-Telangiectasia: Efficacy, Safety, and Novel Biomarker Identification 1 min read Read further: A Phase 2a/b Trial of Triheptanoin for Ataxia-Telangiectasia: Efficacy, Safety, and Novel Biomarker Identification FacebookXPinterestLinkedIn
Article NL C.68(2026) • Internal Medicine Impact of Extreme Thermal Exposure on Geographic... 3 min read
Article NL C.68(2026) • Internal Medicine Evaluating NICE and Surviving Sepsis Guidelines in a... 3 min read
Article NL C.66(2026) • Internal Medicine Evaluating Automated Oxygen Titration Performance... 3 min read
Article NL C.66(2026) • Internal Medicine Machine Learning Risk Model Outperforms TNM Staging in... 3 min read
Article NL C.66(2026) • Internal Medicine Impact of Biological Sex Stratification on Clinical... 3 min read